Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Oliver

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2024
International collaboration of neoadjuvant stereotactic radiosurgery for brain metastases: The INTERNEO individual patient data pooled analysisCristian Udovicich, Kendrick Koo, John Michael Bryant, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous MelanomaTobin Strom, Javier F Torres-Roca, Akash Parekh, et al.
Journal of Neurosurgery|January 22, 2023
Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy aloneAmmoren E Dohm, Joseph D Tang, Matthew N Mills, et al.
Annals of Surgical Oncology|August 4, 2018
Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?Matthew C Perez, Felipe R de Pinho, Amanda Holstein, et al.
Journal of Neuro-Oncology|March 20, 2021
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastasesMatthew N Mills, Chetna Thawani, Nicholas B Figura, et al.
BMC Cancer|May 16, 2021
Capecitabine and stereotactic radiation in the management of breast cancer brain metastasesMatthew N Mills, Afrin Naz, Chetna Thawani, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2023
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastasesAmmoren E Dohm, Justyn Y Nakashima, Hruday Kalagotla, et al.
Breast Cancer Research and Treatment|October 20, 2021
The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIsMatthew N Mills, Thrisha K Potluri, Yuki Kawahara, et al.
Journal of Neuro-Oncology|September 30, 2025
Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional reportVaseem M Khatri, Mariella A Mestres-Villanueva, Sierra Daniel, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2023
Early-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution ExperienceDaniel E Oliver, Jose M Laborde, Deepinder P Singh, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2024
International collaboration of neoadjuvant stereotactic radiosurgery for brain metastases: The INTERNEO individual patient data pooled analysisCristian Udovicich, Kendrick Koo, John Michael Bryant, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous MelanomaTobin Strom, Javier F Torres-Roca, Akash Parekh, et al.
Journal of Neurosurgery|January 22, 2023
Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy aloneAmmoren E Dohm, Joseph D Tang, Matthew N Mills, et al.
Annals of Surgical Oncology|August 4, 2018
Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?Matthew C Perez, Felipe R de Pinho, Amanda Holstein, et al.
Journal of Neuro-Oncology|March 20, 2021
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastasesMatthew N Mills, Chetna Thawani, Nicholas B Figura, et al.
BMC Cancer|May 16, 2021
Capecitabine and stereotactic radiation in the management of breast cancer brain metastasesMatthew N Mills, Afrin Naz, Chetna Thawani, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2023
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastasesAmmoren E Dohm, Justyn Y Nakashima, Hruday Kalagotla, et al.
Breast Cancer Research and Treatment|October 20, 2021
The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIsMatthew N Mills, Thrisha K Potluri, Yuki Kawahara, et al.
Journal of Neuro-Oncology|September 30, 2025
Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional reportVaseem M Khatri, Mariella A Mestres-Villanueva, Sierra Daniel, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2023
Early-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution ExperienceDaniel E Oliver, Jose M Laborde, Deepinder P Singh, et al.
Pageof 5